Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis

NCT01674621 is registered in ClinicalTrials.gov with Radius Health, Inc. as lead sponsor.

NCT NCT01674621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01674621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis
Lead sponsor
Radius Health, Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 25, 2012
Completion date
August 2, 2013
Enrollment
250 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

post menopausal osteoporosis